JNJ-3738 (Compound 148) is the inhibitor for CDK7 with a K i of 21.75 nM. JNJ-3738 inhibits the proliferation of CDK7 WT expressing A549 with pIC 50 of 7.37.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > CDK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.